https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=35901928&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 359019282022091320221013
1095-93271222022SepMolecular and cellular neurosciencesMol Cell NeurosciThe AICD fragment of APP initiates a FoxO3a mediated response via FANCD2.10376010376010.1016/j.mcn.2022.103760S1044-7431(22)00066-5The amyloid precursor protein (APP) is a cell surface protein of uncertain function that is notable for being the parent protein of beta-amyloid. Research around this protein has focussed heavily on the link to Alzheimer's disease and neurodegeneration. However, there is increasing evidence that APP may be linked to neuronal loss through mechanisms independent of beta-amyloid. FoxO3a is a transcription factor associated with neuronal longevity and apoptosis. In neurons, FoxO3a is associated with cell death through pathways that include BIM, a BCL-2 family member. In this study we have shown that APP overexpression increased the cellular levels and activity of FoxO3a. This increased expression and activity is not a result of decreased phosphorylation but is more likely a result of increased nuclear stability due to increased levels of FANCD2, a binding partner of FoxO3a. The changes caused by APP overexpression were shown to be due to the AICD fragment of APP possibly directly inducing transcription increase in FANCD2. These findings strengthen the link between APP metabolism and FoxO3a neuronal activity. This link may be crucial in better understanding the cellular role of APP and its link to neurodegeneration and aging.Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.GreenwoodEleanor KEKDepartment of Life Sciences, University of Bath, Bath BA2 7AY, UK.AngelovaDafina MDMDepartment of Life Sciences, University of Bath, Bath BA2 7AY, UK.BüchnerHadassah M IHMIDepartment of Life Sciences, University of Bath, Bath BA2 7AY, UK.BrownDavid RDRDepartment of Life Sciences, University of Bath, Bath BA2 7AY, UK. Electronic address: bssdrb@bath.ac.uk.engJournal ArticleResearch Support, Non-U.S. Gov't20220725
United StatesMol Cell Neurosci91000951044-74310Amyloid beta-Peptides0Amyloid beta-Protein Precursor0FANCD2 protein, human0FOXO3 protein, human0Fanconi Anemia Complementation Group D2 Protein0Forkhead Box Protein O30Membrane ProteinsIMAlzheimer DiseasemetabolismAmyloid beta-PeptidesmetabolismAmyloid beta-Protein PrecursorgeneticsmetabolismFanconi Anemia Complementation Group D2 ProteingeneticsmetabolismForkhead Box Protein O3geneticsmetabolismHumansMembrane ProteinsmetabolismNeuronsmetabolismAmyloidBIMFANCD2FoxO3aNeurodegenerationDeclaration of competing interest All authors declare that there are no competing interests to note.
20226102022711202272120227296020229146020227281913ppublish3590192810.1016/j.mcn.2022.103760S1044-7431(22)00066-5